COVID Treatment & Management
Sort by:
MedCram
Optimize Health and Immunity (Light Therapy and Melatonin): What Are the Benefits From Optimizing Exposure to Light?
FEATURING
Roger Seheult
- 274 views
- January 28, 2022
- 4
MedCram
COVID-19 Case Report: Vitamin D Deficiency in a Child and Long COVID-19 With Virus Isolated in the GI Tract
FEATURING
Roger Seheult
- 255 views
- January 28, 2022
- 1
This Week in Virology (TWiV)
Effectiveness of Monoclonal Antibodies for Treatment of COVID-19, Efficacy and Safety of Anakinra Plus Standard of Care for Patients with Severe COVID-19, and Defining of Post COVID-19 Condition Among Published Research Studies
FEATURING
Daniel Griffin,
Vincent Racaniello
- 246 views
- August 2, 2023
Meeting Pearls
COVID-19 Manifestation in Pediatric Patients: MIS-C, Cardiac Manifestations, Asthma, and Atopic Disease
FEATURING
Madan Kumar
- 246 views
- July 28, 2021
- 2
MedNews Week
COVID-19 Therapies: Antivirals and Drugs Against Severe Symptoms
FEATURING
Adolfo García-Sastre
- 244 views
- February 14, 2023
GEST - Global Embolization Symposium and Technologies
COVID-19: What You've Always Wanted to Know, but Were Afraid to Ask - Panel Discussion
FEATURING
Janice Newsome,
John Kaufman
- 240 views
- August 21, 2020
- 1
MicrobeTV
The Next Wave of Severe COVID-19
FEATURING
Paul Offit,
Vincent Racaniello
- 237 views
- August 2, 2023
- 2
AACC American Association for Clinical Chemistry
COVID-19 & Cytokine Storm Syndrome: What Is the Criteria for Identifying CSS in Patients? What Are the Complications and Available Treatments? Can You Use Glucocorticoids and Interleukin Targeted Therapies?
FEATURING
Randy Cron
- 236 views
- October 5, 2020
- 2
MedCram
Monoclonal Antibodies for COVID-19 Update: EUA Revoked
FEATURING
Roger Seheult
- 222 views
- February 1, 2022
MicrobeTV
Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Severe COVID-19 Prevention, Association Between SARS-CoV-2 Positivity and Long COVID Duration, and NIH Launching Phase 2 Long-COVID Treatment Trials
FEATURING
Daniel Griffin,
Vincent Racaniello
- 200 views
- August 9, 2023
- 2
Columbia University's Zuckerman Institute
Antiviral Strategy for SARS-CoV-2: Lethal Mutagenesis With Molnupiravir/NHC
FEATURING
Ronald Swanstrom
- 198 views
- November 19, 2021
- 2